NEW THERAPEUTIC APPROACHES AND DRUG DISCOVERY

In the last decade, drug options for different diseases are rapidly increased, but several of these latters remain a significant global health problem and an area of increased awareness among both patients and medical practitioners. Many scientific results have highlighted new targets for drug discovery, including inhibition of inflammatory mediators and newly formed proteins. Epidemiological and prospective studies have, also, potentially proposed the vital role of bioactive substances, present in the food, and/or set in the context of a dietary, in reducing the risk of cancer and cardiovascular diseases. In addition, the study for evaluating new molecules to treat painful conditions are in progress. No pharmacologic interventions, such as antioxidants, deserve equal emphasis both in the prevention and treatment of several age-related diseases, therefore,their use as drugs could be useful. New developments in drug delivery research are likely to have important impacts on pharmaceutical and biomedical industries.

It is evident that, for the complexity of the disease, strategies targeting different multiple systems involved in disease progression are required to maximize the therapeutic benefits of intervention. To this end, there are a number of approaches currently under active evaluation andfor this, the interaction among scientists and industries is required.